In short. A short list for a consultation, including which contributor is being treated, what the plan does not change, and how long any improvement is expected to hold.

Key points

  • If I did nothing for six months, what would be different?
  • A surface state that is stable will still be stable, and the honest answer may be that waiting costs nothing.
  • A pigment problem that is progressing, or a lesion that is changing, gives a different answer.

A consultation about a dull complexion is short, and it is easy to leave without the information that decides whether the plan is reasonable. These are the questions worth asking.

Which contributor is being treated, and how was that decided?

Dead cells, dehydration, pigment and slowed turnover are answered in different ways. A plan should name the dominant one and say how it was identified. If the answer is that all four are being treated together, ask what will be learned from the result, because a change produced by four simultaneous interventions cannot be attributed to any of them.

What will this change, and what will it not change?

Ask for both halves. A treatment that improves surface texture does not change pigment; one that fades pigment does not change texture; nothing on the ladder changes volume, descent or a scar. Asking what the plan does not do is the fastest way to find out whether it is aimed at your actual complaint.

The question that reveals the most

If I did nothing for six months, what would be different? A surface state that is stable will still be stable, and the honest answer may be that waiting costs nothing. A pigment problem that is progressing, or a lesion that is changing, gives a different answer.

How long is the improvement expected to hold?

Ask for the interval in your own case rather than a general figure. The honest answer involves repeat sessions at an interval your skin establishes, plus daily care. A plan that does not mention maintenance has not been thought through to six months.

What are the risks in my skin specifically?

Pigment change after an in-clinic session is the main one, and it matters more in deeper skin tones. Irritation from topical agents is the other, and it can leave more pigment than it removes in skin that marks easily.

What would make you decide not to treat me?

This is the most informative question on the list. Common answers include an expectation that treatment cannot meet, a barrier that needs repairing first, and a finding that belongs with a doctor rather than with a cosmetic plan.

What are the alternatives, including doing nothing?

Every step on this ladder has a rung below it, and doing nothing is a legitimate option at every stage rather than a failure to decide. Ask what the lower rungs would achieve in your case, and how long it would take to know whether they were enough.

Answers that should stop the conversation

  • A guarantee of a specific result, or of a result that will last indefinitely.
  • A package of sessions offered before anyone has examined your skin or named a contributor.
  • A refusal to discuss what the plan does not change, or a discount that expires today.

Why maintenance rather than correction is the honest frame is set out in Why Dull Skin Comes Back. The point at which the ladder stops is stated in The Honest Ceiling for Dull Skin.

Related reading

Frequently asked questions

What is the single most useful question to ask?

Which contributor are we treating, and how was that decided? Dullness has four contributors and they are answered differently, so a plan that does not name one is a plan that cannot be judged. If the answer is that all four are being addressed at once, ask what will be learned from the result, because changing four things together tells you nothing about which one mattered.

Should I expect to leave the first appointment with a plan?

You may leave with an assessment and a proposal, and you should not feel obliged to accept it on the day. A reasonable clinician is comfortable with a patient who takes the plan away and comes back with questions. Pressure to decide immediately, or a price that expires, is information about the seller rather than about the treatment.

What if I am told I need several different treatments?

Ask what each one is for, in what order, and what would happen if you did only the first. A plan built from several steps can be entirely reasonable, but each step should have a stated purpose and a stated interval, and you should be able to say which step addresses which contributor. A list without that structure is a list rather than a plan.

Risks & Limitations

  • Pallor with fatigue, breathlessness or palpitations, yellowing of the eyes or skin, darkening that arrived suddenly or after a medicine, and any mole that is changing are medical findings rather than cosmetic ones, and they are assessed by a doctor before anything is treated.
  • Skin that is being over-exfoliated becomes duller, more reactive and slower to settle. A barrier damaged this way has to be repaired before anything else on the ladder is worth doing.
  • In-clinic surface treatments carry a risk of pigment change that is greater in deeper skin tones, and the change they produce fades unless it is held up by daily care.
  • No rung on the ladder makes skin permanently luminous. Dullness returns as turnover, oil and ultraviolet exposure continue, and maintenance is the honest frame for the whole approach.

When to Seek Care

  • Pallor with breathlessness, palpitations, dizziness or fainting — seek medical assessment.
  • Yellowing of the eyes or skin, dark urine or pale stools — seek medical assessment promptly.
  • A mole or spot that is changing, bleeding, itching or failing to heal — have it examined.
  • After an in-clinic session: blistering, crusting, spreading redness, or pain that is worsening rather than settling.

References & Further Reading

  • American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
  • National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
  • Cochrane Library — systematic reviews
  • Chinese Medical Association Plastic Surgery Branch — clinical guidance

Medically reviewed by Tongchun Mao, MD (毛彤春), Deputy Director & Head of Aesthetic Surgery. Last reviewed: 19 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.